Cookson Peirce & CO Inc Haemonetics Corp Transaction History

Cookson Peirce & CO Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	SELL	$73.85 - $86.14 $73,702 - $85,967	-998 Reduced 6.51%	14,344 $1.13 Million
Q3 2022 Nov 08, 2022	BUY	$63.3 - $78.66 $971,148 - $1.21 Million	15,342 New	15,342 $1.14 Million
Q1 2020 May 04, 2020	SELL	$74.34 - $121.82 $10.1 Million - $16.6 Million	-136,101 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$114.37 - $129.46 $1.12 Million - $1.27 Million	-9,783 Reduced 6.71%	136,101 $15.6 Million
Q3 2019 Nov 05, 2019	BUY	$117.16 - $138.52 $9.91 Million - $11.7 Million	84,609 Added 138.08%	145,884 $18.4 Million
Q2 2019 Jul 31, 2019	BUY	$81.74 - $120.34 $5.01 Million - $7.37 Million	61,275 New	61,275 $0

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.